- Home
- FFIC vs SANA Comparison
FFIC vs SANA Comparison
Compare FFIC & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIC
- SANA
- Stock Information
- Founded
- FFIC 1929
- SANA 2018
- Country
- FFIC United States
- SANA United States
- Employees
- FFIC N/A
- SANA N/A
- Industry
- FFIC Major Banks
- SANA Medicinal Chemicals and Botanical Products
- Sector
- FFIC Finance
- SANA Health Care
- Exchange
- FFIC Nasdaq
- SANA Nasdaq
- Market Cap
- FFIC 454.6M
- SANA 522.4M
- IPO Year
- FFIC 1995
- SANA 2021
- Fundamental
- Price
- FFIC $14.26
- SANA $1.65
- Analyst Decision
- FFIC Hold
- SANA Strong Buy
- Analyst Count
- FFIC 4
- SANA 3
- Target Price
- FFIC $15.50
- SANA $11.50
- AVG Volume (30 Days)
- FFIC 453.4K
- SANA 2.1M
- Earning Date
- FFIC 01-23-2025
- SANA 11-08-2024
- Dividend Yield
- FFIC 6.17%
- SANA N/A
- EPS Growth
- FFIC N/A
- SANA N/A
- EPS
- FFIC 0.87
- SANA N/A
- Revenue
- FFIC $193,714,000.00
- SANA N/A
- Revenue This Year
- FFIC N/A
- SANA N/A
- Revenue Next Year
- FFIC $14.16
- SANA N/A
- P/E Ratio
- FFIC $16.39
- SANA N/A
- Revenue Growth
- FFIC 4.54
- SANA N/A
- 52 Week Low
- FFIC $10.74
- SANA $1.55
- 52 Week High
- FFIC $18.59
- SANA $12.00
- Technical
- Relative Strength Index (RSI)
- FFIC 27.93
- SANA 30.34
- Support Level
- FFIC $13.97
- SANA $1.81
- Resistance Level
- FFIC $15.45
- SANA $2.07
- Average True Range (ATR)
- FFIC 0.59
- SANA 0.26
- MACD
- FFIC -0.42
- SANA -0.04
- Stochastic Oscillator
- FFIC 7.30
- SANA 7.52
About FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.